Iovance Biotherapeutics Inc (IOVA): Next-Year EPS Estimate 43.74%
As of 2026-06-04, Iovance Biotherapeutics Inc (IOVA) has a next-year EPS growth estimate of 43.74%.
On 2026-06-02, analyst consensus for IOVA's next-year EPS growth shifted from 43.59% to 43.74% — a positive change of 0.15 percentage points. The revised estimate has been sustained across 3 subsequent trading sessions. Current-year growth is projected at 49.60%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 43.74%
- EPS growth this year
- 49.60%
- EPS next quarter (est)
- -$0.13
- Last price
- $4.38
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 43.74% | 49.60% | -$0.13 | $4.38 |
| 2026-06-03 | 43.74% | 49.60% | -$0.13 | $3.79 |
| 2026-06-02 | 43.74% | 49.60% | -$0.13 | $4.10 |
| 2026-06-01 | 43.59% | 49.65% | -$0.13 | $3.96 |
| 2026-05-31 | 43.59% | 49.65% | -$0.13 | $4.10 |
| 2026-05-28 | 43.59% | 49.65% | -$0.13 | $4.30 |
| 2026-05-27 | 43.59% | 49.65% | -$0.13 | $4.37 |
| 2026-05-26 | 43.59% | 49.65% | -$0.13 | $4.10 |
| 2026-05-25 | 43.59% | 49.65% | -$0.13 | $4.11 |
| 2026-05-24 | 43.59% | 49.65% | -$0.13 | $4.11 |
| 2026-05-21 | 43.59% | 49.65% | -$0.13 | $3.70 |
| 2026-05-20 | 43.59% | 49.65% | -$0.13 | $3.54 |
| 2026-05-19 | 43.59% | 49.65% | -$0.13 | $3.46 |
| 2026-05-18 | 43.59% | 49.65% | -$0.13 | $3.39 |
| 2026-05-17 | 43.59% | 49.65% | -$0.13 | $3.45 |
| 2026-05-14 | 48.40% | 50.28% | -$0.13 | $3.52 |
| 2026-05-13 | 48.40% | 50.28% | -$0.13 | $3.62 |
| 2026-05-12 | 47.64% | 50.45% | -$0.13 | $3.56 |
| 2026-05-11 | 47.64% | 50.45% | -$0.13 | $3.70 |
| 2026-05-10 | 47.64% | 50.45% | -$0.13 | $3.62 |
| 2026-05-07 | 55.79% | 51.61% | -$0.14 | $3.55 |
| 2026-05-06 | 52.87% | 51.15% | -$0.15 | $4.09 |
| 2026-05-05 | 52.87% | 51.15% | -$0.15 | $3.98 |
| 2026-05-04 | 52.87% | 51.15% | -$0.15 | $3.85 |
| 2026-05-03 | 52.87% | 51.15% | -$0.15 | $3.40 |
| 2026-04-30 | 52.87% | 51.15% | -$0.15 | $3.36 |
| 2026-04-29 | 52.87% | 51.15% | -$0.15 | $3.31 |
| 2026-04-28 | 52.87% | 51.15% | -$0.15 | $3.38 |
| 2026-04-27 | 52.87% | 51.15% | -$0.15 | $3.43 |
| 2026-04-26 | 52.87% | 51.15% | -$0.15 | $3.44 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Iovance Biotherapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Iovance Biotherapeutics Inc (IOVA) has a next-year EPS growth estimate of 43.74%, based on analyst consensus.
When was the latest EPS estimate revision for IOVA?▾
The most recent revision occurred on 2026-06-02, when analysts adjusted the next-year EPS growth estimate from 43.59% to 43.74%.
What sector and industry does Iovance Biotherapeutics Inc belong to?▾
Iovance Biotherapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. IOVA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Iovance Biotherapeutics Inc (IOVA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports